Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Chun-Ming Hong"'
Autor:
Kai-Chun Chang, Tung-Hung Su, Sih-Han Liao, Tai-Chung Tseng, Shang-Chin Huang, Shih-Jer Hsu, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 8, Pp 891-898 (2024)
Background: Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) reduce the risk of hepatocellular carcinoma (HCC) in patients of hepatitis B. This study compared the difference between ETV and TDF on risk of HCC recurrence and mortality in patien
Externí odkaz:
https://doaj.org/article/7edb9804012a43ae9c13ddf3a667c2b3
Autor:
Hao-Che Chang, Tung-Hung Su, Yu-Tsung Huang, Chun-Ming Hong, Wang-Huei Sheng, Po-Ren Hsueh, Jia-Horng Kao
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 1, Pp 55-63 (2024)
Background: Liver dysfunction is common during coronavirus disease 2019 (COVID-19), while its clinical impact and association with chronic hepatitis B (CHB) remain uncertain. We aimed to investigate liver dysfunction in COVID-19 patients and its impa
Externí odkaz:
https://doaj.org/article/1d118e0b6ce84cd1b836948ac2795ed1
Autor:
Meng-Ju Lin, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Chi-Ling Chen, Jyh-Ming Liou, Tai-Chung Tseng, Chen-Hua Liu, Chun-Ming Hong, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 7, Pp 564-573 (2023)
Background/purpose: Distinct hepatitis relapse has been observed after discontinuing entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients. End-of-therapy (EOT) serum cytokines were compared and used for
Externí odkaz:
https://doaj.org/article/2d3aedfe41f741b3ab626b5406e1d37c
Autor:
Tai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, Fumitaka Suzuki, Chieh Chiang, Chun-Ming Hong, Hiromitsu Kumada, Wan-Ting Yang, Tung-Hung Su, Hung-Chih Yang, Chen-Hua Liu, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
JHEP Reports, Vol 6, Iss 1, Pp 100956- (2024)
Background & Aims: Risk scores have been designed to predict the development of hepatocellular carcinoma (HCC) in treatment-naive patients with chronic hepatitis B (CHB). However, little is known about their predictive accuracy in HBeAg-negative pati
Externí odkaz:
https://doaj.org/article/11c9ce8e1ecf47a7a1a62aefefc4a1ba
Autor:
Meng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, Wei-Kai Wu, Shih-Jer Hsu, Tai-Chung Tseng, Sih-Han Liao, Chun-Ming Hong, Hung-Chih Yang, Chun-Jen Liu, Ming-Shiang Wu, Jia-Horng Kao
Publikováno v:
Gut Pathogens, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background Hepatitis B virus (HBV) causes chronic hepatitis B (CHB), liver cirrhosis, and hepatocellular carcinoma. The evolution of human gut microbiota during the progression of HBV-related liver diseases remains unclear. Therefore, we pro
Externí odkaz:
https://doaj.org/article/30df2698b5ed478e80793f1d36f0b497
Autor:
Meng-Ju Lin, Tung-Hung Su, Chieh-Chang Chen, Wei-Kai Wu, Shih-Jer Hsu, Tai-Chung Tseng, Sih-Han Liao, Chun-Ming Hong, Hung-Chih Yang, Chun-Jen Liu, Ming-Shiang Wu, Jia-Horng Kao
Publikováno v:
Gut Pathogens, Vol 15, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/d88046a3925143fea8e8f7a944cd2eca
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Development of gastrointestinal (GI) complications is adversely associated with prognosis in the critically ill. However, little is known about their impact on the outcome of non-critically ill patients. In this study, we aimed to
Externí odkaz:
https://doaj.org/article/235229111a5742fc8aef00e574bb01df
Autor:
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, Hung-Chih Yang, Pei-Jer Chen, Yu-Wen Chen, Jia-Horng Kao, Chun-Jen Liu
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 53, Iss 4, Pp 569-577 (2020)
Background/purpose: Treatment of chronic hepatitis C (CHC) has entered a new era since the introduction of direct-acting antiviral agents (DAAs). Numerous clinical trials have shown that treatment response as well as tolerability of DAAs are superior
Externí odkaz:
https://doaj.org/article/5508e117f20a4221b2b4fe225c484729
Autor:
Chian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Liver Cancer, p 1 (2023)
Introduction: Optimal treatment of hepatocellular carcinoma (HCC) beyond the Milan criteria is in debate. We aimed to identify candidates for surgical resection (SR) in Barcelona Clinic Liver Cancer (BCLC) –A/B HCC beyond the Milan criteria with su
Externí odkaz:
https://doaj.org/article/ee79b781a9a947418047f504358a9fc7
Autor:
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen
Publikováno v:
Viruses, Vol 13, Iss 11, p 2294 (2021)
About 4% of the population in Taiwan are seropositive for anti-HCV Ab and 70% with HCV RNA. To address this high chronic hepatitis C disease load, Taiwan National Health Insurance started reimbursing genotype-specific DAAs in 2017 and pangenotype DAA
Externí odkaz:
https://doaj.org/article/4771619952644a0e85cb664e74106a9b